Synthesis and Biological Activity of Fungal Metabolite, 4-Hydroxy-3-(3'-Methyl-2'-Butenyl)-Benzoic Acid

  • Kim, Hye-Jin (Chemical Genomics Laboratory, Department of Biotechnology, College of Engineering, Yonsei University) ;
  • Kwon, Ho-Jeong (Chemical Genomics Laboratory, Department of Biotechnology, College of Engineering, Yonsei University)
  • Published : 2007.03.31

Abstract

4-Hydroxy-3-(3'-methyl-2'-butenyl)-benzoic acid (HMBA) was previously isolated from Curvularia sp. KF119 as a cell-cycle inhibitor. However, the present study used a novel and practical synthetic method to prepare a large quantity of HMBA. The synthetic HMBA was found to inhibit the cell-cycle progression of HeLa cells with a comparable potency to the natural fungal metabolite. The inhibition of the cell-cycle progression by the synthetic HMBA involved both the activation of $p21^{WAF1}$ and the inhibition of cyclin D1 expression in the cells. Consequently, this new synthetic procedure provides an easy and convenient way to produce or manipulate the original fungal metabolite.

Keywords

References

  1. Buommino, E., R. Nicoletti, G. M. Gaeta, M. Orlando, M. L. Ciavatta, A. Baroni, and M. A. Tufano. 2004. 3-Omethylfunicone, a secondary metabolite produced by Penicillium pinophilum, induces growth arrest and apoptosis in HeLa cells. Cell Prolif. 37: 413-426 https://doi.org/10.1111/j.1365-2184.2004.00323.x
  2. Chen, J. X., Y. Gao, J. W. Liu, Y. X. Tian, J. Zhao, and X. Y. Cui. 2005. Antitumor effects of human ribonuclease inhibitor gene transfected on B16 melanoma cells. Int. J. Biochem. Cell Biol. 37: 1219-1231 https://doi.org/10.1016/j.biocel.2004.11.020
  3. Hitomi, M., T. Nonomura, F. Yokoyama, H. Yoshiji, M. Ogawa, S. Nakai, A. Deguchi, T. Masaki, H. Inoue, Y. Kimura, K. Kurokohchi, N. Uchida, and S. Kuriyama. 2005. In vitro and in vivo antitumor effects of vitamin K5 on hepatocellular carcinoma. Int. J. Oncol. 26: 1337-1344
  4. Florenes, V., M. Skrede, K. Jorgensen, and J. Nesland. 2004. Deacetylase inhibition in malignant melanomas: Impact on cell-cycle regulation and survival. Melanoma Res. 14: 173- 181 https://doi.org/10.1097/01.cmr.0000129576.49313.26
  5. Honda, Y., M. Ueki, G. Okada, R. Onose, R. Usami, K. Horikoshi, and H. Osada. 2001. Isolation, and biological properties of a new cell-cycle inhibitor, curvularol, isolated from Curvularia sp. RK97-F166. J. Antibiot. (Tokyo) 54: 10-16 https://doi.org/10.7164/antibiotics.54.10
  6. Jung, H. J. and H. J. Kwon. 2006. Chemical genomics with natural products. J. Microbiol. Biotechnol. 16: 651-660
  7. Kim, H. J., J. H. Kim, C. H. Lee, and H. J. Kwon. 2006. Gentisyl alcohol, an antioxidant from microbial metabolite, induces angiogenesis in vitro. J. Microbiol. Biotechnol. 16: 475-479
  8. Kim, K. N., J. Lee, D. H. Kim, J. S. Yoo, and H. J. Kwon. 2005. A new synthetic analogue of thymidine, 7-(3-bromophenoxy)- thymidine, inhibits the proliferation of tumor cells. Bioorg. Med. Chem. Lett. 15: 77-79 https://doi.org/10.1016/j.bmcl.2004.10.039
  9. Kim, S. N., W. G. Kim, H. J. Jung, J. S. Shim, H. J. Kim, H. B. Lee, J. T. Han, C. J. Kim, N. I. Baek, I. D. Yoo, and H. J. Kwon. 2004. Cell-cycle inhibitory activity of 4-hydroxy- 3-(3'-methyl-2'-butenyl)-benzoic acid from Curvularia sp. KF119. J. Antibiot. (Tokyo) 57: 605-608 https://doi.org/10.7164/antibiotics.57.605
  10. Lin, R., Y. Lu, S. K. Wetter, P. J. Connolly, I. J. Turchi, W. V. Murray, S. L. Emanuel, R. H. Gruninger, A. R. Fuentes-Pesquera, M. Adams, N. Pandey, S. Moreno-Mazza, S. A. Middleton, and L. K. Jolliffe. 2005. 3-Acyl-2, 6- diaminopyridines as cyclin-dependent kinase inhibitors: Synthesis and biological evaluation. Bioorg. Med. Chem. Lett. 15: 2221-2224 https://doi.org/10.1016/j.bmcl.2005.03.024
  11. Li, X., S. K. Kim, J. S. Kang, H. D. Choi, and B. W. Son. 2006. Radical scavenging hydroxyphenyl ethanoic acid derivatives from a marine-derived fungus. J. Microbiol. Biotechnol. 16: 637-638
  12. Papeleu, P., P. Loyer, T. Vanhaecke, G. Elaut, A. Geerts, C. Guguen-Guillouzo, and V. J. Rogiers. 2003. Trichostatin A induces differential cell-cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes. J. Hepatol. 39: 374-382 https://doi.org/10.1016/S0168-8278(03)00288-5
  13. Shipiro, G. I. and J. W. J. Harper. 1999. Anticancer drug targets: Cell cycle and checkpoint control. Clin. Invest. 104: 1645-1653 https://doi.org/10.1172/JCI9054
  14. Sowa, Y., T. Orita, S. Minamikawa, K. Nakano, T. Mizuno, H. Nonura, and T. Sakai. 1997. Histone deacetylase inhibitor activates the $p21^{WAF1/Cip1}$ gene promoter through the Sp1 sites. Biochem. Biophys. Res. Commun. 241: 142-150 https://doi.org/10.1006/bbrc.1997.7786
  15. Stehelin, D., H. E. Varmus, J. M. Bishop, and P. K. Vogt, 1976. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260: 170-173 https://doi.org/10.1038/260170a0
  16. Xu, M. H. and G. Y. Zhang. 2005. Effect of indomethacin on cell-cycle proteins in colon cancer cell lines. World J. Gastroenterol. 11: 1693-1696 https://doi.org/10.3748/wjg.v11.i11.1693
  17. Welburn, J. P. and J. A. Endicott. 2005. Inhibition of the cell cycle with chemical inhibitors: A targeted approach. Semin. Cell Dev. Biol. 16: 369-381